Abstract
Blinatumomab as a Curative Therapy Option for Relapsed/Refractory Infant Acute Lymphoblastic Leukemia Post-Hematopoietic Stem Cell Transplantation - Case Report
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have